SMMT 8-K 2026-11-04

Summit Therapeutics Inc. (SMMT) 8-K dated 2026-11-04 — accession 0001193125-26-447661.

Summit Therapeutics Inc. (SMMT) is a biotechnology company listed on US.

Summit Therapeutics Inc. filed a 8-K on 2026-11-04. Accession 0001193125-26-447661.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.

Not investment advice. The SMMT SEC hub lists recent forms. The stock page is the research view.